Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketosteril Supplemented Low Protein Diet in Stage V CKD
NCT00364884Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2006
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of Ketosteril in chronic kidney disease (CKD) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoints: Glomerular Filtration Rate and Creatinine Clearance. Status: unknown.
02
Drugs
Ketosteril
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00364884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364884.